Adma Biologics (ADMA) Prepaid Assets (2011 - 2025)

Adma Biologics has reported Prepaid Assets for 14 years, with the latest figure at $7.5 million in Q4 2025.

• For the quarter ending Q4 2025, Prepaid Assets fell 7.11% year-over-year to $7.5 million; the trailing twelve-month figure through Dec 2025 stood at $7.5 million (down 7.11% YoY), and the FY2025 full-year result was $7.5 million, down 7.11% from the prior year.
• Prepaid Assets for Q4 2025 stood at $7.5 million, up from $6.9 million in the prior quarter.
• The five-year high for Prepaid Assets was $9.5 million in Q3 2024, with the low at $3.7 million in Q1 2024.
• Historically, Prepaid Assets has averaged $6.1 million across 5 years, with a median of $5.5 million in 2022.
• The largest YoY upside for Prepaid Assets was 129.59% in 2025 against a maximum downside of 27.4% in 2025.
• Adma Biologics' Prepaid Assets stood at $4.3 million in 2021, then grew by 17.42% to $5.1 million in 2022, then advanced by 4.69% to $5.3 million in 2023, then soared by 50.52% to $8.0 million in 2024, then retreated by 7.11% to $7.5 million in 2025.
• The last three Prepaid Assets figures came in at $7.5 million (Q4 2025), $6.9 million (Q3 2025), and $8.1 million (Q2 2025), per Business Quant data.